Versant Venture Management as of Dec. 31, 2022
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 41.9 | $20M | 499k | 40.65 | |
| Gritstone Oncology Common Stock (GRTS) | 25.4 | $12M | 3.6M | 3.45 | |
| Passage Bio Common Stock (PASG) | 14.2 | $6.8M | 5.0M | 1.38 | |
| CymaBay Therapeutics Common Stock | 7.1 | $3.4M | 544k | 6.27 | |
| Adverum Biotechnologies Common Stock | 6.1 | $2.9M | 5.1M | 0.58 | |
| Aligos Therapeutics Common Stock (ALGS) | 4.6 | $2.2M | 2.3M | 0.95 | |
| Minerva Surgical Common Stock | 0.8 | $374k | 1.7M | 0.22 |
